Log In
Print this Print this

G-Pen Mini

  Manage Alerts
Collapse Summary General Information
Company Xeris Pharmaceuticals Inc.
DescriptionMulti-dose, variable-dose pen for subcutaneous administration of room temperature-stable soluable glucagon
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationHypoglycemia
Indication DetailsTreat mild to moderate hypoglycemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today